Literature DB >> 21057123

Pelvic imaging following chemotherapy and radiation therapy for gynecologic malignancies.

Helen C Addley1, Hebert Alberto Vargas, Penelope L Moyle, Robin Crawford, Evis Sala.   

Abstract

Gynecologic malignancies account for 10%-15% of all malignancies in females. A variety of oncologic options are available depending on organ of origin, histologic diagnosis, and disease grade and stage. Gynecologic malignancies are usually treated with surgery, chemotherapy, or radiation therapy. Posttreatment imaging plays a crucial role in the assessment of treatment response and tumor recurrence. Imaging of the female pelvis following chemotherapy and radiation therapy is particularly challenging due to alteration of the normal anatomy and loss of tissue planes. Expected changes in appearance occur following chemotherapy-radiation therapy, as do complications such as fistulas, proctitis, enteritis, typhlitis, cystitis, and insufficiency fractures. Radiologists should be familiar with both the expected posttreatment imaging findings and the imaging features of common complications to help make the correct interpretation and avoid possible pitfalls. © RSNA, 2010.

Entities:  

Mesh:

Year:  2010        PMID: 21057123      PMCID: PMC6939852          DOI: 10.1148/rg.307105063

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  31 in total

1.  Imaging findings after radiotherapy to the pelvis.

Authors:  R B Iyer; A Jhingran; H Sawaf; H I Libshitz
Journal:  AJR Am J Roentgenol       Date:  2001-11       Impact factor: 3.959

2.  High signals in the uterine cervix on T2-weighted MRI sequences.

Authors:  M De Graef; R Karam; V Juhan; P Y Daclin; A J Maubon; J P Rouanet
Journal:  Eur Radiol       Date:  2002-05-14       Impact factor: 5.315

Review 3.  Multi-detector row CT: spectrum of diseases involving the ileocecal area.

Authors:  Christine Hoeffel; Michel D Crema; Ahcène Belkacem; Louisa Azizi; Maité Lewin; Lionel Arrivé; Jean-Michel Tubiana
Journal:  Radiographics       Date:  2006 Sep-Oct       Impact factor: 5.333

4.  Differentiation between recurrent tumor and benign conditions after treatment of gynecologic pelvic carcinoma: value of dynamic contrast-enhanced subtraction MR imaging.

Authors:  K Kinkel; M Ariche; A A Tardivon; A Spatz; D Castaigne; C Lhomme; D Vanel
Journal:  Radiology       Date:  1997-07       Impact factor: 11.105

Review 5.  Pathophysiology and therapy of chronic radiation-induced injury to the colon.

Authors:  C S Donner
Journal:  Dig Dis       Date:  1998 Jul-Aug       Impact factor: 2.404

6.  Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation.

Authors:  L Portelance; K S Chao; P W Grigsby; H Bennet; D Low
Journal:  Int J Radiat Oncol Biol Phys       Date:  2001-09-01       Impact factor: 7.038

7.  Role of CT in the management of recurrent ovarian cancer.

Authors:  Stacey A Funt; Hedvig Hricak; Nadeem Abu-Rustum; Madhu Mazumdar; Howard Felderman; Dennis S Chi
Journal:  AJR Am J Roentgenol       Date:  2004-02       Impact factor: 3.959

8.  The Frank Ellis memorial lecture: the use of three-dimensional imaging in gynaecological radiation therapy.

Authors:  A N Viswanathan
Journal:  Clin Oncol (R Coll Radiol)       Date:  2008-02       Impact factor: 4.126

9.  The fate of the ovaries after radical hysterectomy and ovarian transposition.

Authors:  D D Feeney; D H Moore; K Y Look; F B Stehman; G P Sutton
Journal:  Gynecol Oncol       Date:  1995-01       Impact factor: 5.482

Review 10.  Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I--malignancies of the cervix, ovary, vagina and vulva.

Authors:  Geoff Delaney; Susannah Jacob; Michael Barton
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

View more
  17 in total

1.  Role of preoperative MR imaging in the evaluation of patients with persistent or recurrent gynaecological malignancies before pelvic exenteration.

Authors:  Olivio F Donati; Yulia Lakhman; Evis Sala; Irene A Burger; Hebert A Vargas; Debra A Goldman; Vaagn Andikyan; Kay J Park; Dennis S Chi; Hedvig Hricak
Journal:  Eur Radiol       Date:  2013-05-08       Impact factor: 5.315

Review 2.  Role of MR Imaging and FDG PET/CT in Selection and Follow-up of Patients Treated with Pelvic Exenteration for Gynecologic Malignancies.

Authors:  Yulia Lakhman; Stephanie Nougaret; Maura Miccò; Chiara Scelzo; Hebert A Vargas; Ramon E Sosa; Elizabeth J Sutton; Dennis S Chi; Hedvig Hricak; Evis Sala
Journal:  Radiographics       Date:  2015 Jul-Aug       Impact factor: 5.333

Review 3.  [Imaging of side effects after radiation therapy].

Authors:  T Welzel; J M Tanner
Journal:  Radiologe       Date:  2018-08       Impact factor: 0.635

4.  Comparison of 18F-FDG PET/MRI and MRI for pre-therapeutic tumor staging of patients with primary cancer of the uterine cervix.

Authors:  Theresia Sarabhai; Benedikt M Schaarschmidt; Axel Wetter; Julian Kirchner; Bahriye Aktas; Michael Forsting; Verena Ruhlmann; Ken Herrmann; Lale Umutlu; Johannes Grueneisen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-08-24       Impact factor: 9.236

5.  Added value of diffusion-weighted MRI in detection of cervical cancer recurrence: comparison with morphologic and dynamic contrast-enhanced MRI sequences.

Authors:  Rita Lucas; João Lopes Dias; Teresa Margarida Cunha
Journal:  Diagn Interv Radiol       Date:  2015 Sep-Oct       Impact factor: 2.630

6.  Magnetic resonance enterography findings of chronic radiation enteritis.

Authors:  Oktay Algin; Baris Turkbey; Evrim Ozmen; Efnan Algin
Journal:  Cancer Imaging       Date:  2011-11-30       Impact factor: 3.909

7.  Uterine perforation and its dosimetric implications in cervical cancer high-dose-rate brachytherapy.

Authors:  Yasir A Bahadur; Maha M Eltaher; Ashraf H Hassouna; Mohammad A Attar; Camelia Constantinescu
Journal:  J Contemp Brachytherapy       Date:  2015-02-04

8.  Evaluation of genitourinary fistulas in pelvic malignancies with etiopathologic correlation: role of cross sectional imaging in detection and management.

Authors:  Anitha Mandava; Veeraiah Koppula; Gaurav Sharma; Meghana Kandati; K V V N Raju; T Subramanyeshwar Rao
Journal:  Br J Radiol       Date:  2020-06-15       Impact factor: 3.039

Review 9.  Imaging side effects and complications of chemotherapy and radiation therapy: a pictorial review from head to toe.

Authors:  Domenico Albano; Massimo Benenati; Antonio Bruno; Federico Bruno; Marco Calandri; Damiano Caruso; Diletta Cozzi; Riccardo De Robertis; Francesco Gentili; Irene Grazzini; Giuseppe Micci; Anna Palmisano; Carlotta Pessina; Paola Scalise; Federica Vernuccio; Antonio Barile; Vittorio Miele; Roberto Grassi; Carmelo Messina
Journal:  Insights Imaging       Date:  2021-06-10

10.  A prospective study of the value of pre- and post-treatment magnetic resonance imaging examinations for advanced cervical cancer.

Authors:  Csaba Csutak; Claudia Ordeanu; Viorica Magdalena Nagy; Diana Cristina Pop; Sorana Daniela Bolboaca; Radu Badea; Liliana Chiorean; Sorin Marian Dudea
Journal:  Clujul Med       Date:  2016-07-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.